Delivery of caffeine through an inhalation route
First Claim
1. An aerosol comprising particles, wherein the particles comprise at least 5 percent by weight of caffeine.
0 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to the delivery of caffeine through an inhalation route. Specifically, it relates to aerosols containing caffeine that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent by weight of caffeine. In a method aspect of the present invention, caffeine is delivered to a mammal through an inhalation route. The method comprises: a) heating a composition, wherein the composition comprises at least 5 percent by weight of caffeine, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles, which is inhaled by the mammal. In a kit aspect of the present invention, a kit for delivering caffeine through an inhalation route to a mammal is provided which comprises: a) a composition comprising at least 5 percent by weight of caffeine; and, b) a device that forms a caffeine containing aerosol from the composition, for inhalation by the mammal.
-
Citations
15 Claims
- 1. An aerosol comprising particles, wherein the particles comprise at least 5 percent by weight of caffeine.
-
9. A method for delivering caffeine to a mammal through an inhalation route, wherein the method comprises:
-
(a) heating a composition, wherein the composition comprises at least 5 percent by weight of caffeine to form a vapor; and
,(b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles which is inhaled by the mammal. - View Dependent Claims (10, 11, 12)
-
-
13. A kit for delivering caffeine through an inhalation route to a mammal, wherein the kit comprises:
-
a) a composition comprising at least 5 percent by weight of caffeine; and
,b) a device that forms a caffeine containing aerosol from the composition for inhalation by the mammal. - View Dependent Claims (14, 15)
-
Specification